article thumbnail

Using new method, study highlights physician turnover trend

SCIENMAG: Medicine & Health

Using an innovative method for measuring doctor turnover, Weill Cornell Medicine researchers determined that between 2010 and 2018, the annual rate at which physicians left their practices increased by 43 percent, from 5.3 percent to 7.6 percent a year.

Doctors 65
article thumbnail

With retinal images and genetic data, researchers predict cardiovascular, metabolic, and other disease risks

Broad Institute

The authors have developed an online user-interface for all of their findings on the Ocular Knowledge Portal , to enable researchers to explore associations between retinal layer thickness, disease and genetics.

Disease 124
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

US states seek $26.4 billion from major pharmaceutical manufacturers and distributors to settle opioid litigation

The Pharma Data

The lawsuit accused the companies of insurance fraud and for downplaying the risks of their opioid painkillers to both doctors and patients. It also helped draft letters to allow doctors to prescribe more of its drugs, and accused Allergan of misrepresenting the safety of its opioids, despite a 2010 FDA warning over its painkiller Kadian. .

article thumbnail

AHA News: Hospice Candidate at 2, She’s Now 13 and Thriving

The Pharma Data

” That was the term the doctors used six months after a third surgery to correct a heart defect that left her struggling to breathe while her lungs continued to fill with fluid. A doctor suggested hospice. Several doctors came in to evaluate what they were seeing. In March 2010, doctors did just that.

Doctors 52
article thumbnail

Gianluca Pirozzi, MD, PhD, Celebrated for Dedication to the Field of Immunology and Rare Disease Research

The Pharma Data

Dr. Pirozzi received a Doctorate of Medicine from Università Campus Bio-Medico di Roma in Italy, a Doctorate of Philosophy in Immunology from Sapienza Università di Roma in Italy, a Post-Doctorate degree in Immunology from the Institut Pasteur in Paris, France, and business training at the London Business School, UK.

Disease 52
article thumbnail

Basel: a centre for ground-breaking oncology 

Drug Discovery World

SOTIO has been building a diverse biotechnology portfolio through its own R&D, collaborations and investments since 2010, and now employs around 240 personnel across Europe and the US. Emmerth studied biology at ETH Zurich and gained his doctorate at the Friedrich Miescher Institute (Novartis) in Basel. He has worked for F.

article thumbnail

Not all neoantigens are created equal

Drug Target Review

Sergio holds a PhD from Dartmouth Medical School and from 2004 to 2010 he held a post-doctoral position at Memorial Sloan-Kettering Cancer Center. In 2016 he co-led ground-breaking research supporting the key role of clonal tumour neoantigens in the immune response to cancer; research that underpins the Achilles approach.